Form 4: Ceribell Inc. Insider Trades: Director Sells Shares

Xingjuan Chao, Director and President/CEO of Ceribell, Inc., reported transactions involving the sale and acquisition of common stock and stock options on July 7, 2026, executed under a Rule 10b5-1 trading plan.

Summary

• Xingjuan Chao, a Director and the President and CEO of Ceribell, Inc., engaged in several transactions on July 7, 2026.
• These transactions included the sale of 14,000 shares of common stock at a weighted average price of $19.90, with individual sales ranging from $19.69 to $20.27.
• Additionally, 1,446 shares and 23,554 shares of common stock were acquired through the exercise of stock options at a price of $4.70 per share.
• Following these transactions, Chao beneficially owns 802,317 shares directly and 369,088 shares indirectly through the ACP 2021 Trust.
• The transactions were conducted under a Rule 10b5-1 trading plan, which is intended to satisfy affirmative defense conditions for insider trading.
• One stock option grant for 1,446 shares vests monthly, while another for 23,554 shares is fully vested and exercisable.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as neutral to slightly negative due to the significant sale of shares by a key executive, despite the use of a Rule 10b5-1 plan.

Positives

• The use of a Rule 10b5-1 trading plan indicates a pre-arranged and structured approach to insider transactions, potentially mitigating concerns about market timing.
• Acquisition of shares through stock option exercises at a lower price ($4.70) than the sale price ($19.90) suggests a profitable exercise and sale strategy.
• The reporting person continues to hold a significant number of shares, both directly (802,317) and indirectly (369,088), indicating continued investment in the company.

Negatives

• The sale of a substantial number of shares (14,000) by a key executive and director could be interpreted negatively by the market, suggesting a lack of confidence or a need for personal liquidity.
• The weighted average sale price of $19.90, while within a range, represents a disposal of equity by a high-level insider.

Risks

• The primary risk is the market's perception of insider selling, which can negatively impact investor sentiment and stock price, regardless of the underlying reasons or the existence of a trading plan.
• Future sales under the Rule 10b5-1 plan could continue to exert downward pressure on the stock price if not balanced by positive company news or strong buying interest.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions.

Management Comments

• The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
• The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.69 to $20.27, inclusive.
• The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
• The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities.
• The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
• The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
• The stock option is fully vested and currently exercisable.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard for reporting insider transactions. The use of a Rule 10b5-1 plan is common practice for executives to diversify holdings or manage personal finances while adhering to insider trading regulations. The specific details of the sales and option exercises provide insight into executive compensation and potential liquidity events within the company.

Stakeholder Impact

• Shareholders may view the sale of shares by a director and CEO with caution, potentially impacting investor confidence.
• Employees holding stock options may be influenced by the executive's exercise and sale strategy, though the vesting schedule for their own options remains unchanged.
• Creditors and suppliers are unlikely to be directly impacted by this insider transaction.

Next Steps

• Monitor future Form 4 filings for continued insider selling or buying activity.
• Observe the market's reaction to these transactions and any subsequent price movements.

Key Dates

Recommendation

The filing reports insider transactions, including sales by a key executive. While the use of a Rule 10b5-1 plan mitigates some concerns, significant selling by a director and CEO warrants a cautious 'hold' stance until further positive developments or clarity on the company's strategic direction emerge.

Keywords

Form 4, Insider Trading, Ceribell Inc., CBLL, Xingjuan Chao, Stock Options, Rule 10b5-1, Beneficial Ownership, SEC Filing, Executive Transactions